394 is the total number of securities Iguana Healthcare Management, LLC has owned. The longest Iguana Healthcare Management, LLC has owned a single stock is 17 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| BIIB | BIOGEN INC | 12 | 5 | 1.15% | 3.90% | 7.51% | Q4 2013 | Q1 2018 | 17 |
| RARE | ULTRAGENYX PHARMACEUTI... | 17 | 17 | 0.88% | 3.05% | 6.72% | Q1 2014 | Q1 2018 | 17 |
| MRK | MERCK & CO INC NEW | 10 | 6 | 1.21% | 3.03% | 5.38% | Q4 2013 | Q1 2018 | 16 |
| CELG | CELGENE CORP | 15 | 15 | 2.80% | 5.34% | 7.88% | Q2 2014 | Q4 2017 | 15 |
| AERI | AERIE PHARMACEUTICALS INC | 8 | 1 | 0.33% | 1.87% | 3.31% | Q4 2013 | Q4 2017 | 15 |
| GILD | GILEAD SCIENCES INC | 14 | 14 | 0.84% | 3.31% | 6.68% | Q4 2013 | Q1 2017 | 14 |
| ESPR | ESPERION THERAPEUTICS ... | 8 | 1 | 0.20% | 2.92% | 7.79% | Q4 2013 | Q1 2018 | 14 |
| SUPN | SUPERNUS PHARMACEUTICA... | 13 | 1 | 0.41% | 1.53% | 2.79% | Q1 2014 | Q4 2017 | 14 |
| DERM | DERMIRA INC | 14 | 14 | 0.44% | 1.34% | 2.72% | Q4 2014 | Q1 2018 | 14 |
| AMGN | AMGEN INC | 8 | 5 | 1.92% | 4.11% | 6.50% | Q4 2013 | Q1 2017 | 13 |
| ZBH | ZIMMER HLDGS INC | 8 | 2 | 0.91% | 2.78% | 4.90% | Q4 2013 | Q4 2017 | 13 |
| CI | CIGNA CORPORATION | 5 | 3 | 1.07% | 2.88% | 6.50% | Q4 2013 | Q1 2018 | 12 |
| OMED | ONCOMED PHARMACEUTICAL... | 12 | 12 | 0.31% | 1.62% | 3.17% | Q2 2015 | Q1 2018 | 12 |
| XLRN | ACCELERON PHARMA INC | 11 | 1 | 0.40% | 1.52% | 4.05% | Q2 2014 | Q3 2017 | 12 |
| IPXL | IMPAX LABORATORIES INC | 10 | 1 | 0.59% | 1.07% | 1.81% | Q4 2013 | Q1 2017 | 12 |
| SCYX | SCYNEXIS INC | 12 | 12 | 0.11% | 0.30% | 0.48% | Q2 2015 | Q1 2018 | 12 |
| GBT | GLOBAL BLOOD THERAPEUT... | 11 | 11 | 1.08% | 2.30% | 3.65% | Q3 2015 | Q1 2018 | 11 |
| SPNC | SPECTRANETICS CORP | 7 | 4 | 0.25% | 1.12% | 2.39% | Q2 2014 | Q2 2017 | 11 |
| PFE | PFIZER INC | 4 | 1 | 1.13% | 2.76% | 8.78% | Q1 2014 | Q4 2017 | 10 |
| IMMU | IMMUNOMEDICS INC | 8 | 1 | 0.08% | 1.69% | 4.74% | Q1 2015 | Q1 2018 | 10 |
| GWPH | GW PHARMACEUTICALS PLC | 8 | 1 | 0.69% | 1.52% | 2.16% | Q1 2014 | Q2 2017 | 10 |
| AXDX | ACCELERATE DIAGNOSTICS... | 9 | 1 | 0.17% | 1.00% | 2.37% | Q4 2013 | Q4 2016 | 10 |
| ALXN | ALEXION PHARMACEUTICAL... | 6 | 1 | 1.41% | 2.79% | 4.13% | Q1 2014 | Q1 2018 | 9 |
| NUVA | NUVASIVE INC | 9 | 9 | 0.75% | 1.67% | 2.82% | Q2 2015 | Q2 2017 | 9 |
| NVDQ | NOVADAQ TECHNOLOGIES INC | 9 | 9 | 0.80% | 1.28% | 2.05% | Q4 2013 | Q4 2015 | 9 |
| PBYI | PUMA BIOTECHNOLOGY INC | 6 | 1 | 0.32% | 1.20% | 2.48% | Q4 2013 | Q4 2017 | 9 |
| ELGX | ENDOLOGIX INC | 8 | 1 | 0.18% | 0.88% | 1.59% | Q4 2013 | Q1 2017 | 9 |
| MDCO | MEDICINES CO | 8 | 8 | 0.82% | 2.87% | 6.05% | Q2 2016 | Q1 2018 | 8 |
| CLVS | CLOVIS ONCOLOGY INC | 8 | 8 | 0.50% | 2.62% | 4.18% | Q2 2016 | Q1 2018 | 8 |
| TRNX | TORNIER N V | 8 | 8 | 1.18% | 1.73% | 2.23% | Q4 2013 | Q3 2015 | 8 |
| KTWO | K2M GROUP HLDGS INC | 8 | 8 | 0.31% | 1.65% | 2.75% | Q2 2016 | Q1 2018 | 8 |
| MRUS | MERUS N V | 8 | 8 | 0.65% | 1.30% | 2.11% | Q2 2016 | Q1 2018 | 8 |
| T107PS | WRIGHT MED GROUP INC | 8 | 8 | 0.83% | 1.19% | 1.49% | Q4 2013 | Q3 2015 | 8 |
| MDRX | ALLSCRIPTS HEALTHCARE ... | 8 | 8 | 0.37% | 1.08% | 1.39% | Q2 2015 | Q1 2017 | 8 |
| TSRO | TESARO INC | 4 | 1 | 0.24% | 1.05% | 1.89% | Q4 2013 | Q1 2018 | 8 |
| SGMO | SANGAMO THERAPEUTICS INC | 5 | 3 | 0.17% | 0.92% | 1.65% | Q4 2015 | Q1 2018 | 8 |
| ADMA | ADMA BIOLOGICS INC | 8 | 8 | 0.24% | 0.70% | 1.82% | Q2 2016 | Q1 2018 | 8 |
| AKAOQ | ACHAOGEN INC | 6 | 2 | 0.26% | 0.55% | 0.85% | Q1 2014 | Q1 2018 | 8 |
| ABBV | ABBVIE INC | 4 | 3 | 0.98% | 2.49% | 3.86% | Q2 2014 | Q4 2017 | 7 |
| ABT | ABBOTT LABS | 6 | 1 | 0.98% | 1.93% | 2.79% | Q1 2015 | Q1 2018 | 7 |
| GKOS | GLAUKOS CORP | 7 | 7 | 0.77% | 1.74% | 2.54% | Q1 2016 | Q3 2017 | 7 |
| MYL | MYLAN N V | 3 | 1 | 0.44% | 1.71% | 4.00% | Q2 2015 | Q1 2018 | 7 |
| CLDX | CELLDEX THERAPEUTICS I... | 7 | 7 | 0.60% | 1.40% | 2.76% | Q4 2013 | Q2 2015 | 7 |
| THC | TENET HEALTHCARE CORP | 4 | 3 | 0.40% | 1.39% | 1.86% | Q2 2014 | Q3 2016 | 7 |
| HZNP | HORIZON PHARMA PLC | 6 | 1 | 0.48% | 1.38% | 2.19% | Q3 2014 | Q4 2016 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 4 | 3 | 0.42% | 1.04% | 2.01% | Q1 2016 | Q4 2017 | 7 |
| XENT | INTERSECT ENT INC | 7 | 7 | 0.51% | 0.99% | 1.58% | Q2 2016 | Q4 2017 | 7 |
| ETRM | ENTEROMEDICS INC | 7 | 7 | 0.21% | 0.96% | 1.68% | Q4 2013 | Q2 2015 | 7 |
| HWAY | HEALTHWAYS INC | 7 | 7 | 0.19% | 0.95% | 1.56% | Q2 2015 | Q4 2016 | 7 |
| CCXI | CHEMOCENTRYX INC | 7 | 7 | 0.27% | 0.79% | 1.32% | Q2 2016 | Q4 2017 | 7 |
| CBAY | CYMABAY THERAPEUTICS INC | 5 | 2 | 0.19% | 0.62% | 1.46% | Q3 2014 | Q3 2017 | 7 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 6 | 1 | 0.11% | 0.56% | 1.40% | Q3 2015 | Q3 2017 | 7 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 6 | 1 | 0.19% | 0.53% | 1.06% | Q3 2014 | Q1 2018 | 7 |
| RXDX | IGNYTA INC | 4 | 1 | 0.24% | 0.51% | 0.85% | Q1 2014 | Q3 2017 | 7 |
| PACB | PACIFIC BIOSCIENCES CA... | 5 | 2 | 0.23% | 0.39% | 0.55% | Q1 2015 | Q1 2017 | 7 |
| SPDR S&P 500 ETF TR | 1 | 1 | 2.28% | 5.36% | 8.66% | Q4 2013 | Q1 2018 | 6 | |
| SHPG | SHIRE PLC | 2 | 1 | 2.05% | 3.38% | 5.28% | Q4 2014 | Q1 2018 | 6 |
| ANTM | ANTHEM INC | 3 | 3 | 1.12% | 2.66% | 5.51% | Q1 2015 | Q4 2016 | 6 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 4 | 1 | 0.87% | 1.83% | 2.81% | Q4 2013 | Q3 2017 | 6 |
| ALKS | ALKERMES PLC | 5 | 1 | 0.53% | 1.51% | 2.04% | Q4 2013 | Q2 2016 | 6 |
| MDVN | MEDIVATION INC | 4 | 1 | 0.24% | 1.43% | 4.46% | Q4 2013 | Q2 2016 | 6 |
| MZOR | MAZOR ROBOTICS LTD | 6 | 6 | 0.08% | 1.18% | 2.29% | Q4 2015 | Q1 2017 | 6 |
| DPLO | DIPLOMAT PHARMACY INC | 6 | 6 | 0.38% | 0.71% | 1.33% | Q4 2016 | Q1 2018 | 6 |
| AGTC | APPLIED GENETIC TECHNO... | 5 | 1 | 0.26% | 0.62% | 1.01% | Q2 2015 | Q1 2017 | 6 |
| EPZM | EPIZYME INC | 2 | 2 | 0.26% | 0.57% | 0.83% | Q2 2015 | Q2 2017 | 6 |
| MYL | MYLAN INC | 5 | 5 | 1.94% | 2.52% | 2.84% | Q4 2013 | Q4 2014 | 5 |
| AET | AETNA INC NEW | 3 | 2 | 1.78% | 2.47% | 3.16% | Q3 2015 | Q3 2017 | 5 |
| TEVA | TEVA PHARMACEUTICAL IN... | 3 | 2 | 1.22% | 1.86% | 3.24% | Q1 2014 | Q4 2015 | 5 |
| KPTI | KARYOPHARM THERAPEUTIC... | 5 | 5 | 1.10% | 1.74% | 2.42% | Q1 2017 | Q1 2018 | 5 |
| ANAB | ANAPTYSBIO INC | 5 | 5 | 0.69% | 1.49% | 2.62% | Q1 2017 | Q1 2018 | 5 |
| PETX | ARATANA THERAPEUTICS INC | 4 | 1 | 0.40% | 1.01% | 1.55% | Q3 2014 | Q1 2016 | 5 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 5 | 5 | 0.47% | 1.00% | 1.81% | Q3 2015 | Q3 2016 | 5 |
| AVNR | AVANIR PHARMACEUTICALS... | 5 | 5 | 0.42% | 0.98% | 1.64% | Q4 2013 | Q4 2014 | 5 |
| LJPC | LA JOLLA PHARMACEUTICA... | 3 | 2 | 0.43% | 0.85% | 1.37% | Q1 2014 | Q4 2015 | 5 |
| DYAX | DYAX CORP | 5 | 5 | 0.42% | 0.84% | 1.19% | Q1 2014 | Q1 2015 | 5 |
| CTMX | CYTOMX THERAPEUTICS INC | 5 | 5 | 0.53% | 0.82% | 1.22% | Q1 2017 | Q1 2018 | 5 |
| CYTK | CYTOKINETICS INC | 3 | 2 | 0.45% | 0.80% | 1.23% | Q4 2013 | Q2 2016 | 5 |
| DEPO | DEPOMED INC | 3 | 1 | 0.24% | 0.54% | 0.81% | Q4 2013 | Q4 2015 | 5 |
| FLXN | FLEXION THERAPEUTICS INC | 5 | 5 | 0.31% | 0.54% | 0.73% | Q1 2014 | Q1 2015 | 5 |
| TNDM | TANDEM DIABETES CARE INC | 5 | 5 | 0.06% | 0.34% | 0.54% | Q1 2016 | Q1 2017 | 5 |
| ONCOMED PHARMACEUTICAL... | 3 | 2 | 0.10% | 0.26% | 0.37% | Q4 2015 | Q1 2017 | 5 | |
| MEIP | MEI PHARMA INC | 4 | 1 | 0.11% | 0.23% | 0.52% | Q4 2014 | Q3 2016 | 5 |
| MDT | MEDTRONIC INC | 4 | 4 | 3.13% | 4.14% | 4.55% | Q1 2014 | Q4 2014 | 4 |
| MERCK & CO INC NEW | 2 | 1 | 1.46% | 2.53% | 3.62% | Q4 2013 | Q2 2017 | 4 | |
| AGN | ALLERGAN PLC | 3 | 1 | 1.06% | 2.03% | 3.44% | Q4 2016 | Q4 2017 | 4 |
| MDT | MEDTRONIC PLC | 2 | 1 | 1.00% | 2.02% | 2.75% | Q2 2015 | Q2 2017 | 4 |
| BMY | BRISTOL MYERS SQUIBB CO | 3 | 1 | 1.25% | 1.81% | 2.08% | Q3 2016 | Q1 2018 | 4 |
| JUNO | JUNO THERAPEUTICS INC | 4 | 4 | 1.10% | 1.61% | 1.86% | Q1 2017 | Q4 2017 | 4 |
| LGND | LIGAND PHARMACEUTICALS... | 3 | 1 | 1.14% | 1.60% | 2.25% | Q4 2013 | Q1 2015 | 4 |
| EW | EDWARDS LIFESCIENCES CORP | 2 | 1 | 0.50% | 1.59% | 3.36% | Q4 2013 | Q2 2017 | 4 |
| ENDP | ENDO INTL PLC | 4 | 4 | 0.63% | 1.58% | 2.26% | Q1 2015 | Q4 2015 | 4 |
| INCY | INCYTE CORP | 2 | 2 | 0.62% | 1.26% | 2.16% | Q4 2013 | Q1 2018 | 4 |
| DXCM | DEXCOM INC | 1 | 1 | 0.71% | 1.26% | 1.71% | Q4 2013 | Q1 2018 | 4 |
| BMRN | BIOMARIN PHARMACEUTICA... | 3 | 1 | 0.79% | 0.90% | 0.96% | Q1 2014 | Q1 2016 | 4 |
| EXEL | EXELIXIS INC | 3 | 1 | 0.22% | 0.84% | 1.60% | Q1 2016 | Q1 2018 | 4 |
| LHCG | LHC GROUP INC | 3 | 1 | 0.60% | 0.80% | 0.93% | Q3 2016 | Q4 2017 | 4 |
| NERV | MINERVA NEUROSCIENCES INC | 4 | 4 | 0.40% | 0.78% | 1.13% | Q2 2016 | Q1 2017 | 4 |
| KITE | KITE PHARMA INC | 3 | 1 | 0.48% | 0.73% | 1.02% | Q2 2015 | Q3 2016 | 4 |
| ADMS | ADAMAS PHARMACEUTICALS... | 3 | 1 | 0.47% | 0.68% | 1.06% | Q4 2015 | Q1 2018 | 4 |
| CORI | CORIUM INTL INC | 4 | 4 | 0.42% | 0.64% | 0.83% | Q2 2017 | Q1 2018 | 4 |
| VNDA | VANDA PHARMACEUTICALS INC | 3 | 1 | 0.28% | 0.61% | 0.76% | Q1 2014 | Q3 2015 | 4 |
| FLML | FLAMEL TECHNOLOGIES SA | 2 | 1 | 0.18% | 0.58% | 0.95% | Q2 2014 | Q3 2016 | 4 |
| MRNS | MARINUS PHARMACEUTICAL... | 3 | 1 | 0.25% | 0.40% | 0.57% | Q3 2015 | Q1 2018 | 4 |
| BAX | BAXTER INTL INC | 3 | 3 | 2.48% | 3.64% | 4.36% | Q4 2015 | Q2 2016 | 3 |
| ISHARES TR | 1 | 1 | 2.02% | 3.41% | 4.16% | Q2 2014 | Q4 2016 | 3 | |
| HUM | HUMANA INC | 2 | 1 | 2.25% | 3.14% | 3.64% | Q1 2015 | Q1 2018 | 3 |
| VRX | VALEANT PHARMACEUTICAL... | 3 | 3 | 0.84% | 2.62% | 4.56% | Q2 2015 | Q4 2015 | 3 |
| HCA | HCA HOLDINGS INC | 2 | 1 | 1.57% | 2.18% | 2.86% | Q2 2014 | Q2 2016 | 3 |
| LLY | LILLY ELI & CO | 2 | 1 | 1.89% | 2.06% | 2.33% | Q1 2016 | Q3 2017 | 3 |
| STJ | ST JUDE MED INC | 2 | 1 | 1.70% | 2.02% | 2.30% | Q2 2014 | Q2 2015 | 3 |
| ALEXION PHARMACEUTICAL... | 2 | 1 | 1.50% | 1.86% | 2.38% | Q2 2016 | Q2 2017 | 3 | |
| AMGEN INC | 2 | 1 | 1.31% | 1.65% | 2.26% | Q4 2013 | Q3 2014 | 3 | |
| ISIS | ISIS PHARMACEUTICALS INC | 2 | 1 | 0.91% | 1.61% | 2.17% | Q2 2014 | Q2 2015 | 3 |
| SNY | SANOFI | 2 | 1 | 0.45% | 1.56% | 2.20% | Q3 2014 | Q2 2017 | 3 |
| ARNA | ARENA PHARMACEUTICALS INC | 3 | 3 | 0.84% | 1.52% | 2.60% | Q3 2017 | Q1 2018 | 3 |
| CIGNA CORPORATION | 3 | 3 | 1.16% | 1.49% | 1.99% | Q2 2016 | Q4 2016 | 3 | |
| CAH | CARDINAL HEALTH INC | 1 | 1 | 1.11% | 1.28% | 1.52% | Q1 2015 | Q3 2017 | 3 |
| SRRA | SIERRA ONCOLOGY INC | 3 | 3 | 0.51% | 1.27% | 1.94% | Q3 2017 | Q1 2018 | 3 |
| WBA | WALGREENS BOOTS ALLIAN... | 2 | 1 | 0.51% | 1.23% | 1.73% | Q2 2016 | Q1 2017 | 3 |
| AVXS | AVEXIS INC | 3 | 3 | 0.93% | 1.14% | 1.39% | Q2 2017 | Q4 2017 | 3 |
| ALDR | ALDER BIOPHARMACEUTICA... | 3 | 3 | 0.77% | 1.13% | 1.74% | Q3 2016 | Q1 2017 | 3 |
| PCRX | PACIRA PHARMACEUTICALS... | 1 | 1 | 0.90% | 1.03% | 1.26% | Q4 2015 | Q1 2017 | 3 |
| CMRX | CHIMERIX INC | 2 | 1 | 0.39% | 0.98% | 1.46% | Q4 2013 | Q4 2014 | 3 |
| SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.55% | 0.88% | 1.27% | Q4 2013 | Q3 2016 | 3 |
| IONS | IONIS PHARMACEUTICALS INC | 2 | 1 | 0.42% | 0.79% | 1.31% | Q3 2016 | Q4 2017 | 3 |
| WVE | WAVE LIFE SCIENCES LTD | 3 | 3 | 0.58% | 0.79% | 1.14% | Q2 2017 | Q4 2017 | 3 |
| GW PHARMACEUTICALS PLC | 1 | 1 | 0.43% | 0.76% | 1.18% | Q3 2014 | Q3 2016 | 3 | |
| IMDZ | IMMUNE DESIGN CORP | 3 | 3 | 0.36% | 0.74% | 0.98% | Q1 2015 | Q3 2015 | 3 |
| BKD | BROOKDALE SR LIVING INC | 3 | 3 | 0.54% | 0.73% | 0.91% | Q3 2015 | Q1 2016 | 3 |
| P103PS | NPS PHARMACEUTICALS INC | 2 | 1 | 0.45% | 0.68% | 0.81% | Q4 2013 | Q3 2014 | 3 |
| OSUR | ORASURE TECHNOLOGIES INC | 3 | 3 | 0.29% | 0.65% | 0.98% | Q3 2014 | Q1 2015 | 3 |
| CTLT | CATALENT INC | 3 | 3 | 0.33% | 0.65% | 0.81% | Q3 2017 | Q1 2018 | 3 |
| CHRS | COHERUS BIOSCIENCES INC | 3 | 3 | 0.52% | 0.62% | 0.78% | Q4 2015 | Q2 2016 | 3 |
| SSH | SUNSHINE HEART INC | 3 | 3 | 0.26% | 0.61% | 1.02% | Q4 2013 | Q2 2014 | 3 |
| ZGNX | ZOGENIX INC | 2 | 1 | 0.39% | 0.60% | 0.73% | Q4 2015 | Q3 2017 | 3 |
| VYGR | VOYAGER THERAPEUTICS INC | 3 | 3 | 0.28% | 0.56% | 0.86% | Q3 2017 | Q1 2018 | 3 |
| CELLDEX THERAPEUTICS I... | 2 | 1 | 0.41% | 0.56% | 0.74% | Q4 2013 | Q3 2014 | 3 | |
| ARRY | ARRAY BIOPHARMA INC | 2 | 1 | 0.48% | 0.53% | 0.57% | Q4 2013 | Q4 2016 | 3 |
| SUPERNUS PHARMACEUTICA... | 1 | 1 | 0.36% | 0.51% | 0.77% | Q4 2013 | Q3 2015 | 3 | |
| IMMUNOMEDICS INC | 2 | 1 | 0.10% | 0.44% | 0.75% | Q2 2015 | Q2 2017 | 3 | |
| EGLTQ | EGALET CORP | 3 | 3 | 0.11% | 0.40% | 0.65% | Q1 2014 | Q3 2014 | 3 |
| ARIA | ARIAD PHARMACEUTICALS INC | 3 | 3 | 0.23% | 0.35% | 0.42% | Q3 2015 | Q1 2016 | 3 |
| NEOVASC INC | 3 | 3 | 0.25% | 0.29% | 0.34% | Q1 2017 | Q3 2017 | 3 | |
| GENN | GENESIS HEALTHCARE INC | 3 | 3 | 0.11% | 0.29% | 0.43% | Q2 2015 | Q4 2015 | 3 |
| OBSV | OBSEVA SA | 3 | 3 | 0.11% | 0.13% | 0.14% | Q1 2017 | Q3 2017 | 3 |
| SELECT SECTOR SPDR TR | 1 | 1 | 4.69% | 8.27% | 11.85% | Q2 2015 | Q4 2015 | 2 | |
| AMGEN INC | 2 | 2 | 4.56% | 5.13% | 5.70% | Q1 2014 | Q2 2014 | 2 | |
| PFIZER INC | 2 | 2 | 4.23% | 4.59% | 4.94% | Q2 2015 | Q3 2015 | 2 | |
| SPDR SERIES TRUST | 1 | 1 | 1.44% | 3.09% | 4.73% | Q1 2016 | Q1 2018 | 2 | |
| RCPT | RECEPTOS INC | 2 | 2 | 1.66% | 2.31% | 2.96% | Q3 2014 | Q4 2014 | 2 |
| CLOVIS ONCOLOGY INC | 2 | 2 | 1.11% | 2.26% | 3.41% | Q3 2017 | Q4 2017 | 2 | |
| HZNP | HORIZON PHARMA INC | 2 | 2 | 1.88% | 2.06% | 2.24% | Q1 2014 | Q2 2014 | 2 |
| BIOGEN INC | 1 | 1 | 1.40% | 1.65% | 1.91% | Q1 2016 | Q3 2016 | 2 | |
| DHR | DANAHER CORP DEL | 2 | 2 | 1.51% | 1.58% | 1.66% | Q3 2017 | Q4 2017 | 2 |
| REGENERON PHARMACEUTICALS | 1 | 1 | 0.99% | 1.46% | 1.93% | Q3 2014 | Q1 2016 | 2 | |
| LILLY ELI & CO | 1 | 1 | 1.07% | 1.42% | 1.77% | Q1 2014 | Q3 2016 | 2 | |
| SLXP | SALIX PHARMACEUTICALS INC | 2 | 2 | 1.25% | 1.42% | 1.58% | Q2 2014 | Q3 2014 | 2 |
| TORNIER N V | 1 | 1 | 0.32% | 1.40% | 2.48% | Q4 2013 | Q3 2014 | 2 | |
| MYOK | MYOKARDIA INC | 2 | 2 | 1.28% | 1.33% | 1.37% | Q4 2017 | Q1 2018 | 2 |
| ESPERION THERAPEUTICS ... | 1 | 1 | 0.25% | 1.31% | 2.38% | Q3 2016 | Q1 2018 | 2 | |
| BIOMARIN PHARMACEUTICA... | 1 | 1 | 1.26% | 1.27% | 1.28% | Q1 2014 | Q2 2017 | 2 | |
| ABBVIE INC | 1 | 1 | 1.26% | 1.27% | 1.28% | Q3 2015 | Q2 2016 | 2 | |
| MEDICINES CO | 1 | 1 | 0.60% | 1.26% | 1.92% | Q2 2016 | Q1 2017 | 2 | |
| ABBOTT LABS | 1 | 1 | 0.95% | 1.25% | 1.55% | Q2 2014 | Q2 2015 | 2 | |
| ARTHROCARE CORP | 2 | 2 | 0.22% | 1.18% | 2.14% | Q4 2013 | Q1 2014 | 2 | |
| WALGREENS BOOTS ALLIAN... | 2 | 2 | 1.03% | 1.13% | 1.24% | Q4 2016 | Q1 2017 | 2 | |
| MERCK & CO INC NEW | 1 | 1 | 0.97% | 1.12% | 1.27% | Q3 2014 | Q1 2016 | 2 | |
| GSK | GLAXOSMITHKLINE PLC | 2 | 2 | 0.69% | 1.12% | 1.54% | Q4 2017 | Q1 2018 | 2 |
| NBS | NEOSTEM INC | 2 | 2 | 0.65% | 1.10% | 1.56% | Q4 2013 | Q1 2014 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.99% | 1.04% | 1.10% | Q1 2016 | Q4 2016 | 2 |
| IPCM | IPC HEALTHCARE INC | 2 | 2 | 0.69% | 1.00% | 1.31% | Q1 2015 | Q2 2015 | 2 |
| ACRS | ACLARIS THERAPEUTICS INC | 2 | 2 | 0.81% | 0.96% | 1.11% | Q4 2016 | Q1 2017 | 2 |
| SANOFI | 1 | 1 | 0.41% | 0.96% | 1.51% | Q3 2014 | Q2 2017 | 2 | |
| TTPH | TETRAPHASE PHARMACEUTI... | 2 | 2 | 0.75% | 0.95% | 1.16% | Q1 2015 | Q2 2015 | 2 |
| IMPAX LABORATORIES INC | 2 | 2 | 0.68% | 0.95% | 1.22% | Q4 2013 | Q1 2014 | 2 | |
| BRISTOL MYERS SQUIBB CO | 1 | 1 | 0.67% | 0.92% | 1.17% | Q1 2016 | Q1 2017 | 2 | |
| VKTX | VIKING THERAPEUTICS INC | 2 | 2 | 0.60% | 0.84% | 1.08% | Q4 2017 | Q1 2018 | 2 |
| SAGE | SAGE THERAPEUTICS INC | 2 | 2 | 0.67% | 0.81% | 0.96% | Q3 2015 | Q4 2015 | 2 |
| AZN | ASTRAZENECA PLC | 2 | 2 | 0.77% | 0.79% | 0.82% | Q4 2016 | Q1 2017 | 2 |
| BIOS | BIOSCRIP INC | 2 | 2 | 0.77% | 0.78% | 0.78% | Q2 2016 | Q3 2016 | 2 |
| INCYTE CORP | 1 | 1 | 0.48% | 0.77% | 1.06% | Q1 2016 | Q3 2017 | 2 | |
| BRKR | BRUKER CORP | 2 | 2 | 0.73% | 0.76% | 0.79% | Q4 2013 | Q1 2014 | 2 |
| ONCE | SPARK THERAPEUTICS INC | 2 | 2 | 0.27% | 0.76% | 1.25% | Q2 2016 | Q3 2016 | 2 |
| WOOF | VCA INC | 2 | 2 | 0.27% | 0.76% | 1.24% | Q3 2015 | Q4 2015 | 2 |
| HTWR | HEARTWARE INTL INC | 2 | 2 | 0.35% | 0.75% | 1.16% | Q4 2015 | Q1 2016 | 2 |
| RDUS | RADIUS HEALTH INC | 1 | 1 | 0.71% | 0.73% | 0.75% | Q4 2015 | Q2 2016 | 2 |
| ELOS | SYNERON MEDICAL LTD | 2 | 2 | 0.64% | 0.72% | 0.79% | Q3 2014 | Q4 2014 | 2 |
| PMC | PHARMERICA CORP | 2 | 2 | 0.65% | 0.70% | 0.75% | Q2 2016 | Q3 2016 | 2 |
| KURA | KURA ONCOLOGY INC | 1 | 1 | 0.62% | 0.68% | 0.74% | Q3 2017 | Q1 2018 | 2 |
| DBVT | DBV TECHNOLOGIES S A | 2 | 2 | 0.44% | 0.64% | 0.84% | Q1 2015 | Q2 2015 | 2 |
| MGNX | MACROGENICS INC | 2 | 2 | 0.43% | 0.62% | 0.82% | Q2 2016 | Q3 2016 | 2 |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 2 | 2 | 0.46% | 0.61% | 0.76% | Q4 2017 | Q1 2018 | 2 |
| AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.33% | 0.60% | 0.88% | Q3 2014 | Q2 2015 | 2 | |
| XNCR | XENCOR INC | 1 | 1 | 0.48% | 0.58% | 0.69% | Q2 2017 | Q1 2018 | 2 |
| SPARK THERAPEUTICS INC | 2 | 2 | 0.28% | 0.55% | 0.82% | Q2 2015 | Q3 2015 | 2 | |
| CYCC | CYCLACEL PHARMACEUTICA... | 2 | 2 | 0.42% | 0.53% | 0.63% | Q4 2013 | Q1 2014 | 2 |
| ARWR | ARROWHEAD RESH CORP | 1 | 1 | 0.28% | 0.50% | 0.71% | Q3 2014 | Q3 2015 | 2 |
| RARX | RA PHARMACEUTICALS INC | 2 | 2 | 0.45% | 0.49% | 0.53% | Q4 2016 | Q1 2017 | 2 |
| RAD | RITE AID CORP | 1 | 1 | 0.25% | 0.49% | 0.73% | Q4 2014 | Q2 2017 | 2 |
| RVNC | REVANCE THERAPEUTICS INC | 1 | 1 | 0.41% | 0.48% | 0.55% | Q3 2015 | Q2 2016 | 2 |
| CSLT | CASTLIGHT HEALTH INC | 2 | 2 | 0.31% | 0.48% | 0.65% | Q1 2015 | Q2 2015 | 2 |
| CNAT | CONATUS PHARMACEUTICAL... | 2 | 2 | 0.41% | 0.47% | 0.52% | Q2 2015 | Q3 2015 | 2 |
| GILEAD SCIENCES INC | 1 | 1 | 0.42% | 0.46% | 0.49% | Q1 2014 | Q3 2016 | 2 | |
| PTC THERAPEUTICS INC | 1 | 1 | 0.28% | 0.45% | 0.63% | Q3 2015 | Q3 2017 | 2 | |
| ITCI | INTRA CELLULAR THERAPI... | 2 | 2 | 0.40% | 0.45% | 0.51% | Q1 2016 | Q2 2016 | 2 |
| FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.36% | 0.43% | 0.50% | Q4 2013 | Q3 2017 | 2 |
| ESPERION THERAPEUTICS ... | 2 | 2 | 0.39% | 0.43% | 0.46% | Q2 2015 | Q3 2015 | 2 | |
| AFMD | AFFIMED N V | 1 | 1 | 0.36% | 0.40% | 0.42% | Q2 2015 | Q1 2018 | 2 |
| SRNE | SORRENTO THERAPEUTICS INC | 2 | 2 | 0.30% | 0.35% | 0.41% | Q1 2014 | Q2 2014 | 2 |
| ARIAD PHARMACEUTICALS INC | 1 | 1 | 0.12% | 0.35% | 0.57% | Q3 2015 | Q1 2016 | 2 | |
| ZGNX | ZOGENIX INC | 2 | 2 | 0.20% | 0.34% | 0.49% | Q4 2013 | Q1 2014 | 2 |
| DRNA | DICERNA PHARMACEUTICAL... | 2 | 2 | 0.32% | 0.33% | 0.33% | Q2 2015 | Q3 2015 | 2 |
| FLDM | FLUIDIGM CORP DEL | 2 | 2 | 0.18% | 0.24% | 0.30% | Q1 2016 | Q2 2016 | 2 |
| GI | ENDOCHOICE HLDGS INC | 2 | 2 | 0.22% | 0.23% | 0.25% | Q1 2016 | Q2 2016 | 2 |
| STEM | STEMCELLS INC | 2 | 2 | 0.16% | 0.22% | 0.28% | Q4 2013 | Q1 2014 | 2 |
| PPHM | PEREGRINE PHARMACEUTIC... | 2 | 2 | 0.14% | 0.17% | 0.19% | Q3 2015 | Q4 2015 | 2 |
| MSTX | MAST THERAPEUTICS INC | 2 | 2 | 0.15% | 0.15% | 0.16% | Q1 2014 | Q2 2014 | 2 |
| DEXCOM INC | 1 | 1 | 5.06% | 5.06% | 5.06% | Q3 2015 | Q3 2015 | 1 | |
| XLV | SELECT SECTOR SPDR TR | 1 | 1 | 4.13% | 4.13% | 4.13% | Q4 2014 | Q4 2014 | 1 |
| SELECT SECTOR SPDR TR | 1 | 1 | 3.41% | 3.41% | 3.41% | Q3 2014 | Q3 2014 | 1 | |
| IWM | ISHARES | 1 | 1 | 3.18% | 3.18% | 3.18% | Q4 2013 | Q4 2013 | 1 |
| B108PS | ACTAVIS PLC | 1 | 1 | 3.13% | 3.13% | 3.13% | Q1 2015 | Q1 2015 | 1 |
| GW PHARMACEUTICALS PLC | 1 | 1 | 3.08% | 3.08% | 3.08% | Q3 2016 | Q3 2016 | 1 | |
| CELGENE CORP | 1 | 1 | 2.80% | 2.80% | 2.80% | Q3 2016 | Q3 2016 | 1 | |
| IWM | ISHARES TR | 1 | 1 | 2.62% | 2.62% | 2.62% | Q1 2015 | Q1 2015 | 1 |
| JOHNSON & JOHNSON | 1 | 1 | 2.27% | 2.27% | 2.27% | Q1 2014 | Q1 2014 | 1 | |
| XBI | SPDR SERIES TRUST | 1 | 1 | 2.25% | 2.25% | 2.25% | Q4 2014 | Q4 2014 | 1 |
| MCK | MCKESSON CORP | 1 | 1 | 2.18% | 2.18% | 2.18% | Q3 2015 | Q3 2015 | 1 |
| MEDTRONIC INC | 1 | 1 | 2.13% | 2.13% | 2.13% | Q1 2014 | Q1 2014 | 1 | |
| CLOVIS ONCOLOGY INC | 1 | 1 | 2.12% | 2.12% | 2.12% | Q2 2017 | Q2 2017 | 1 | |
| CNC | CENTENE CORP DEL | 1 | 1 | 2.11% | 2.11% | 2.11% | Q1 2018 | Q1 2018 | 1 |
| PERRIGO CO PLC | 1 | 1 | 2.04% | 2.04% | 2.04% | Q2 2014 | Q2 2014 | 1 | |
| AETNA INC NEW | 1 | 1 | 2.01% | 2.01% | 2.01% | Q2 2015 | Q2 2015 | 1 | |
| CELGENE CORP | 1 | 1 | 2.00% | 2.00% | 2.00% | Q2 2014 | Q2 2014 | 1 | |
| F113PS | COVIDIEN PLC | 1 | 1 | 1.94% | 1.94% | 1.94% | Q4 2013 | Q4 2013 | 1 |
| ASTRAZENECA PLC | 1 | 1 | 1.93% | 1.93% | 1.93% | Q2 2017 | Q2 2017 | 1 | |
| LH | LABORATORY CORP AMER H... | 1 | 1 | 1.86% | 1.86% | 1.86% | Q1 2018 | Q1 2018 | 1 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 1.73% | 1.73% | 1.73% | Q1 2015 | Q1 2015 | 1 |
| 5100PS | VOLCANO CORPORATION | 1 | 1 | 1.73% | 1.73% | 1.73% | Q4 2014 | Q4 2014 | 1 |
| ARTC | ARTHROCARE CORP | 1 | 1 | 1.72% | 1.72% | 1.72% | Q4 2013 | Q4 2013 | 1 |
| UNITED THERAPEUTICS CO... | 1 | 1 | 1.72% | 1.72% | 1.72% | Q3 2014 | Q3 2014 | 1 | |
| BAXTER INTL INC | 1 | 1 | 1.70% | 1.70% | 1.70% | Q1 2014 | Q1 2014 | 1 | |
| CBIO | CATALYST BIOSCIENCES INC | 1 | 1 | 1.70% | 1.70% | 1.70% | Q1 2018 | Q1 2018 | 1 |
| ZSAN | ZOSANO PHARMA CORP | 1 | 1 | 1.66% | 1.66% | 1.66% | Q1 2018 | Q1 2018 | 1 |
| BIIB | BIOGEN IDEC INC | 1 | 1 | 1.64% | 1.64% | 1.64% | Q4 2014 | Q4 2014 | 1 |
| FOREST LABS INC | 1 | 1 | 1.60% | 1.60% | 1.60% | Q4 2013 | Q4 2013 | 1 | |
| LILLY ELI & CO | 1 | 1 | 1.59% | 1.59% | 1.59% | Q2 2016 | Q2 2016 | 1 | |
| CYTOKINETICS INC | 1 | 1 | 1.59% | 1.59% | 1.59% | Q1 2014 | Q1 2014 | 1 | |
| PFIZER INC | 1 | 1 | 1.58% | 1.58% | 1.58% | Q3 2014 | Q3 2014 | 1 | |
| VERTEX PHARMACEUTICALS... | 1 | 1 | 1.55% | 1.55% | 1.55% | Q2 2014 | Q2 2014 | 1 | |
| RCKT | ROCKET PHARMACEUTICALS... | 1 | 1 | 1.54% | 1.54% | 1.54% | Q1 2018 | Q1 2018 | 1 |
| IPXL | IMPAX LABORATORIES INC | 1 | 1 | 1.53% | 1.53% | 1.53% | Q4 2014 | Q4 2014 | 1 |
| ARMO | ARMO BIOSCIENCES INC | 1 | 1 | 1.48% | 1.48% | 1.48% | Q1 2018 | Q1 2018 | 1 |
| ILMN | ILLUMINA INC | 1 | 1 | 1.43% | 1.43% | 1.43% | Q2 2016 | Q2 2016 | 1 |
| ITMN | INTERMUNE INC | 1 | 1 | 1.26% | 1.26% | 1.26% | Q4 2013 | Q4 2013 | 1 |
| ASPX | AUSPEX PHARMACEUTICALS... | 1 | 1 | 1.23% | 1.23% | 1.23% | Q3 2014 | Q3 2014 | 1 |
| TEVA PHARMACEUTICAL IN... | 1 | 1 | 1.22% | 1.22% | 1.22% | Q1 2014 | Q1 2014 | 1 | |
| FGEN | FIBROGEN INC | 1 | 1 | 1.19% | 1.19% | 1.19% | Q3 2017 | Q3 2017 | 1 |
| LABORATORY CORP AMER H... | 1 | 1 | 1.14% | 1.14% | 1.14% | Q1 2014 | Q1 2014 | 1 | |
| AKCA | AKCEA THERAPEUTICS INC | 1 | 1 | 1.13% | 1.13% | 1.13% | Q4 2017 | Q4 2017 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 1.11% | 1.11% | 1.11% | Q1 2018 | Q1 2018 | 1 |
| MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 1.11% | 1.11% | 1.11% | Q1 2018 | Q1 2018 | 1 |
| TVTY | TIVITY HEALTH INC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q1 2017 | Q1 2017 | 1 |
| EVHC | ENVISION HEALTHCARE HL... | 1 | 1 | 1.07% | 1.07% | 1.07% | Q4 2015 | Q4 2015 | 1 |
| ABLX | ABLYNX NV | 1 | 1 | 1.05% | 1.05% | 1.05% | Q4 2017 | Q4 2017 | 1 |
| QDEL | QUIDEL CORP | 1 | 1 | 1.05% | 1.05% | 1.05% | Q4 2014 | Q4 2014 | 1 |
| EDWARDS LIFESCIENCES CORP | 1 | 1 | 1.00% | 1.00% | 1.00% | Q2 2014 | Q2 2014 | 1 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2016 | Q1 2016 | 1 |
| AAAP | ADVANCED ACCELERATOR A... | 1 | 1 | 0.96% | 0.96% | 0.96% | Q4 2016 | Q4 2016 | 1 |
| AGN | ALLERGAN INC | 1 | 1 | 0.95% | 0.95% | 0.95% | Q3 2014 | Q3 2014 | 1 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 1 | 1 | 0.95% | 0.95% | 0.95% | Q1 2018 | Q1 2018 | 1 |
| GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.94% | 0.94% | 0.94% | Q3 2016 | Q3 2016 | 1 | |
| HCP | HCP INC | 1 | 1 | 0.91% | 0.91% | 0.91% | Q1 2015 | Q1 2015 | 1 |
| MDXG | MIMEDX GROUP INC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q4 2013 | Q4 2013 | 1 |
| AERIE PHARMACEUTICALS INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2016 | Q3 2016 | 1 | |
| MDT | MEDTRONIC INC | 1 | 1 | 0.87% | 0.87% | 0.87% | Q4 2014 | Q4 2014 | 1 |
| QUEST DIAGNOSTICS INC | 1 | 1 | 0.87% | 0.87% | 0.87% | Q4 2013 | Q4 2013 | 1 | |
| INSM | INSMED INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q3 2017 | Q3 2017 | 1 |
| VRTX | VERTEX PHARMACEUTICALS... | 1 | 1 | 0.85% | 0.85% | 0.85% | Q4 2013 | Q4 2013 | 1 |
| ZIMMER BIOMET HLDGS INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q4 2015 | Q4 2015 | 1 | |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.84% | 0.84% | 0.84% | Q1 2015 | Q1 2015 | 1 |
| ECYT | ENDOCYTE INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q1 2014 | Q1 2014 | 1 |
| ASTRAZENECA PLC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q4 2016 | Q4 2016 | 1 | |
| A | AGILENT TECHNOLOGIES INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q4 2013 | Q4 2013 | 1 |
| HEALTH NET INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q2 2015 | Q2 2015 | 1 | |
| RTRX | RETROPHIN INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q3 2016 | Q3 2016 | 1 |
| UNITED THERAPEUTICS CO... | 1 | 1 | 0.78% | 0.78% | 0.78% | Q4 2013 | Q4 2013 | 1 | |
| STRYKER CORP | 1 | 1 | 0.76% | 0.76% | 0.76% | Q4 2015 | Q4 2015 | 1 | |
| CERN | CERNER CORP | 1 | 1 | 0.76% | 0.76% | 0.76% | Q1 2018 | Q1 2018 | 1 |
| RADIUS HEALTH INC | 1 | 1 | 0.75% | 0.75% | 0.75% | Q2 2016 | Q2 2016 | 1 | |
| ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 0.74% | 0.74% | 0.74% | Q4 2014 | Q4 2014 | 1 |
| LIGAND PHARMACEUTICALS... | 1 | 1 | 0.73% | 0.73% | 0.73% | Q2 2014 | Q2 2014 | 1 | |
| UNH | UNITEDHEALTH GROUP INC | 1 | 1 | 0.72% | 0.72% | 0.72% | Q2 2016 | Q2 2016 | 1 |
| ZLTQ | ZELTIQ AESTHETICS INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q4 2015 | Q4 2015 | 1 |
| IMPAX LABORATORIES INC | 1 | 1 | 0.70% | 0.70% | 0.70% | Q2 2014 | Q2 2014 | 1 | |
| BIOVERATIV INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q1 2017 | Q1 2017 | 1 | |
| WELLCARE HEALTH PLANS INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q2 2016 | Q2 2016 | 1 | |
| RGNX | REGENXBIO INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q4 2017 | Q4 2017 | 1 |
| TDOC | TELADOC INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q3 2017 | Q3 2017 | 1 |
| PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q1 2015 | Q1 2015 | 1 |
| THOR | THORATEC CORP | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2013 | Q4 2013 | 1 |
| ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 0.62% | 0.62% | 0.62% | Q4 2013 | Q4 2013 | 1 |
| NLNK | NEWLINK GENETICS CORP | 1 | 1 | 0.62% | 0.62% | 0.62% | Q2 2014 | Q2 2014 | 1 |
| ACHC | ACADIA HEALTHCARE COMP... | 1 | 1 | 0.62% | 0.62% | 0.62% | Q3 2016 | Q3 2016 | 1 |
| SAGE THERAPEUTICS INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2016 | Q2 2016 | 1 | |
| CNMD | CONMED CORP | 1 | 1 | 0.61% | 0.61% | 0.61% | Q4 2013 | Q4 2013 | 1 |
| SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q1 2018 | Q1 2018 | 1 |
| ASND | ASCENDIS PHARMA A S | 1 | 1 | 0.60% | 0.60% | 0.60% | Q3 2017 | Q3 2017 | 1 |
| MCRB | SERES THERAPEUTICS INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q2 2016 | Q2 2016 | 1 |
| MEDIVATION INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2016 | Q1 2016 | 1 | |
| NOVARTIS A G | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2014 | Q1 2014 | 1 | |
| OPHT | OPHTHOTECH CORP | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2016 | Q3 2016 | 1 |
| ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.58% | 0.58% | 0.58% | Q1 2016 | Q1 2016 | 1 | |
| ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.56% | 0.56% | 0.56% | Q2 2016 | Q2 2016 | 1 | |
| LDRH | LDR HLDG CORP | 1 | 1 | 0.56% | 0.56% | 0.56% | Q1 2016 | Q1 2016 | 1 |
| MEDICINES CO | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2013 | Q4 2013 | 1 | |
| SPDR SERIES TRUST | 1 | 1 | 0.53% | 0.53% | 0.53% | Q4 2016 | Q4 2016 | 1 | |
| BRUKER CORP | 1 | 1 | 0.53% | 0.53% | 0.53% | Q4 2013 | Q4 2013 | 1 | |
| SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2018 | Q1 2018 | 1 |
| PODD | INSULET CORP | 1 | 1 | 0.53% | 0.53% | 0.53% | Q4 2013 | Q4 2013 | 1 |
| INSMED INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2014 | Q1 2014 | 1 | |
| CATAMARAN CORP | 1 | 1 | 0.52% | 0.52% | 0.52% | Q1 2014 | Q1 2014 | 1 | |
| TXMD | THERAPEUTICSMD INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q1 2015 | Q1 2015 | 1 |
| ZFGN | ZAFGEN INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2015 | Q3 2015 | 1 |
| PHARMERICA CORP | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2016 | Q3 2016 | 1 | |
| KND | KINDRED HEALTHCARE INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2015 | Q1 2015 | 1 |
| ZYNE | ZYNERBA PHARMACEUTICAL... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2017 | Q1 2017 | 1 |
| IVTY | INVUITY INC | 1 | 1 | 0.49% | 0.49% | 0.49% | Q3 2016 | Q3 2016 | 1 |
| PRTK | PARATEK PHARMACEUTICAL... | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2017 | Q3 2017 | 1 |
| MYLAN N V | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2017 | Q1 2017 | 1 | |
| ILLUMINA INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q4 2015 | Q4 2015 | 1 | |
| HAE | HAEMONETICS CORP | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2015 | Q1 2015 | 1 |
| XLRN | ACCELERON PHARMA INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q4 2014 | Q4 2014 | 1 |
| FIVE PRIME THERAPEUTIC... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q3 2016 | Q3 2016 | 1 | |
| PHARMACYCLICS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2014 | Q1 2014 | 1 | |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2015 | Q1 2015 | 1 |
| TBPH | THERAVANCE BIOPHARMA INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2017 | Q1 2017 | 1 |
| ACHN | ACHILLION PHARMACEUTIC... | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2014 | Q4 2014 | 1 |
| PRTA | PROTHENA CORP PLC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q1 2014 | Q1 2014 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2014 | Q4 2014 | 1 |
| OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2015 | Q3 2015 | 1 |
| INFINITY PHARMACEUTICA... | 1 | 1 | 0.41% | 0.41% | 0.41% | Q4 2013 | Q4 2013 | 1 | |
| WRIGHT MED GROUP INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2014 | Q3 2014 | 1 | |
| HOLOGIC INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q1 2014 | Q1 2014 | 1 | |
| TNET | TRINET GROUP INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2016 | Q1 2016 | 1 |
| BLUE | BLUEBIRD BIO INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2016 | Q1 2016 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2014 | Q4 2014 | 1 |
| MYOV | MYOVANT SCIENCES LTD | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2016 | Q4 2016 | 1 |
| EDWARDS LIFESCIENCES CORP | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2013 | Q4 2013 | 1 | |
| SANGAMO BIOSCIENCES INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2013 | Q4 2013 | 1 | |
| SAREPTA THERAPEUTICS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2016 | Q1 2016 | 1 | |
| XBI | SPDR SERIES TRUST | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2016 | Q4 2016 | 1 |
| EXELIXIS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2017 | Q3 2017 | 1 | |
| SPARK THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2015 | Q2 2015 | 1 | |
| DEPOMED INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2014 | Q2 2014 | 1 | |
| BIOSCRIP INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2014 | Q1 2014 | 1 | |
| EPIZYME INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2014 | Q1 2014 | 1 | |
| PRAH | PRA HEALTH SCIENCES INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2016 | Q3 2016 | 1 |
| SERES THERAPEUTICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2016 | Q2 2016 | 1 | |
| SLTM | SOLTA MED INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2013 | Q4 2013 | 1 |
| WMGI | WRIGHT MED GROUP N V | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2017 | Q4 2017 | 1 |
| CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2016 | Q1 2016 | 1 |
| ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2016 | Q3 2016 | 1 |
| NEVRO CORP | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2015 | Q3 2015 | 1 | |
| AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2017 | Q1 2017 | 1 |
| NEWLINK GENETICS CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2017 | Q4 2017 | 1 | |
| CADX | CADENCE PHARMACEUTICAL... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2013 | Q4 2013 | 1 |
| SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2018 | Q1 2018 | 1 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2016 | Q2 2016 | 1 |
| MEIP | MEI PHARMA INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2014 | Q4 2014 | 1 |
| KERX | KERYX BIOPHARMACEUTICA... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2014 | Q4 2014 | 1 |
| SUNSHINE HEART INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2014 | Q2 2014 | 1 | |
| NOVADAQ TECHNOLOGIES INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2015 | Q2 2015 | 1 | |
| FWP | FORWARD PHARMA A/S | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2016 | Q1 2016 | 1 |
| TLOG | TETRALOGIC PHARMACEUTI... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2015 | Q1 2015 | 1 |
| MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2014 | Q1 2014 | 1 | |
| IGNYTA INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2017 | Q3 2017 | 1 | |
| FLAMEL TECHNOLOGIES SA | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2015 | Q2 2015 | 1 | |
| AMARIN CORP PLC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2013 | Q4 2013 | 1 | |
| EXELIXIS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2016 | Q2 2016 | 1 | |
| TRXC | TRANSENTERIX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2017 | Q4 2017 | 1 |
| DERMIRA INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2016 | Q1 2016 | 1 | |
| FOUNDATION MEDICINE INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2014 | Q1 2014 | 1 | |
| NOVAVAX INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2016 | Q2 2016 | 1 | |
| QDEL | QUIDEL CORP | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2014 | Q4 2014 | 1 |
| RIGL | RIGEL PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2016 | Q2 2016 | 1 |
| ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2016 | Q1 2016 | 1 | |
| HORIZON PHARMA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2014 | Q1 2014 | 1 | |
| AQXP | AQUINOX PHARMACEUTICAL... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2015 | Q4 2015 | 1 |
| ONCOMED PHARMACEUTICAL... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2016 | Q3 2016 | 1 | |
| ZIOPHARM ONCOLOGY INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2015 | Q2 2015 | 1 | |
| MEI PHARMA INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2015 | Q2 2015 | 1 | |
| RIGEL PHARMACEUTICALS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2016 | Q2 2016 | 1 | |
| ENTEROMEDICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2014 | Q3 2014 | 1 | |
Download | |||||||||
The securities at the top of the list , including BIOGEN INC, ULTRAGENYX PHARMACEUTICAL IN, and MERCK & CO INC NEW, are the highest-conviction holdings of Iguana Healthcare Management, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Iguana Healthcare Management, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Iguana Healthcare Management, LLC owns currently or has owned in the past.